Sunstone today announced that Novo Holdings A/S has joined as Limited Partner (LP) in Sunstone’s latest fund; Sunstone Life Science Ventures Fund IV (“Sunstone IV”)

Sunstone has been collaborating with Novo Seeds and Novo Ventures, both a part of Novo Holdings, for many years and in several portfolio companies. The investment signifies the relationship Sunstone has established with Novo Holdings, and it supports Sunstone’s approach to developing early stage biotech companies.

Press inquiries should be adressed to: